BETA BLOCKERS, ANGIOTENSIN-CONVERTING ENZYME …
BETA BLOCKERS, ANGIOTENSIN-CONVERTING ENZYME INHIBITORS OR ANGIOTENSIN RECEPTOR BLOCKERS, AND STATINS REDUCE MORTALITY IN PATIENTS WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
H.M. Lai, W.S. Aronow, A. Kruger, H. Desai, H. Amin, W.H. Frishman, M. Cohen,
C. Sorbera
New York Medical College, Valhalla, NY, USA
Background: The association of different cardiovascular drugs with mortality in patients with implantable cardioverter-defibrillators (ICDs) needs to be investigated.
Methods: In an academic cardiology practice, 965 patients who received an ICD according to American College of Cardiology/American Heart Association guidelines were followed for mortality. The 965 patients included 778 men and 187 women, mean age 70±14 years. Follow-up was 32 ± 33 months.
Results: Death occurred in 208 of 965 patients (22%). Death occurred in 199 of 871 patients (23%) with a left ventricular ejection fraction (LVEF) ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
Related searches
- angiotensin converting enzyme ii
- angiotensin converting enzyme inhibitor
- angiotensin converting enzyme normal range
- angiotensin converting enzyme serum
- angiotensin converting enzyme labcorp
- angiotensin converting enzyme 2 receptor
- angiotensin converting enzyme and lungs
- angiotensin converting enzyme high
- angiotensin converting enzyme inhibitor class
- angiotensin converting enzyme inhibitor list
- angiotensin converting enzyme inhibitors
- angiotensin converting enzyme location